Phoenix announces investment team promotions

Phoenix is pleased to announce four promotions within its investment team. James Squires has been promoted to Partner, and James Chiang, Richard Hill and Victoria Wain have been promoted to Investment Director.

James Squires joined Phoenix in 2013 and leads the firm’s financial services investment activity. He has been involved in a number of Phoenix’s investments, including Mobius Life, Redington and Key Retirement Group, and is an investor director on the boards of Mobius Life and Redington. Before joining Phoenix, James spent four years in corporate finance at DC Advisory.

James Chiang joined Phoenix in 2017 and works across a range of sectors including business & technology services and financial services. He has been involved in investments such as Rayner Surgical, Nexus and Universally Speaking. Prior to Phoenix, James worked at PwC, where he was part of the corporate finance and transaction services groups.

Richard Hill focuses on a range of sectors, including business & technology services, media & information and healthcare, and has worked on investments including Capital Economics, Nineteen and 1000heads. Richard joined Phoenix in 2017 from Deloitte, where he was a member of the corporate finance team.

Victoria Wain joined Phoenix in 2018 and works across several sectors including healthcare and consumer & leisure. She has been involved in a number of Phoenix’s investments, including Setfords and Spy Alarms. Prior to Phoenix, Victoria was a member of PwC’s corporate finance and transaction services teams.

David Burns, Managing Partner at Phoenix, said: “We are delighted to have James join the Partnership and to see James, Richard and Victoria promoted to Investment Director; they have each made a significant contribution to the firm, and their promotions are thoroughly deserved. We all look forward to their continued success.”

These promotions follow a record few months for Phoenix. So far in 2021, the firm has completed two investments, in Setfords and Universally Speaking, and has achieved four exits, including the sale of healthcare businesses Rayner Surgical and Sygnature Discovery, both of which delivered strong returns for investors in Phoenix’s 2016 Fund.